Oxygen Concentrators Market Size & Growth [2033]

Oxygen Concentrators Market Overview

The Oxygen Concentrators Market size was valued at USD 2659.95 million in 2024 and is expected to reach USD 4021.56 million by 2033, growing at a CAGR of 4.7% from 2025 to 2033.

The oxygen concentrators market has witnessed significant expansion due to rising respiratory illnesses, surging elderly populations, and a heightened need for non-invasive oxygen therapy solutions. In 2023, global demand surpassed 7.1 million units, with an estimated 61% attributed to home healthcare applications. Portable oxygen concentrators accounted for more than 3.2 million units, driven by increased patient mobility needs.

The United States, China, and India collectively contributed to over 45% of global shipments. COVID-19 and post-pandemic respiratory complications further accelerated the adoption rate in both developed and emerging economies. Over 25,000 healthcare institutions added oxygen concentrators to their emergency response infrastructure between 2022 and 2024. The fixed oxygen concentrators segment grew consistently across hospitals, with over 2.9 million units deployed globally in 2023. Countries in Latin America and Southeast Asia have also scaled national healthcare efforts by subsidizing over 820,000 oxygen concentrators to bridge medical infrastructure gaps. Technological advancements such as noise reduction, lightweight lithium-ion batteries, and integrated digital monitoring systems have enhanced user comfort and device efficiency. The ongoing transition to portable and battery-operated units reflects a long-term shift in consumer preference from bulkier oxygen tanks to compact, user-friendly concentrators.

Key Findings

Top Driver reason: Increased prevalence of chronic obstructive pulmonary disease and respiratory disorders.

Top Country/Region: The United States dominated the market in 2023 with over 1.8 million units deployed nationwide.

Top Segment: Portable oxygen concentrators led the market, with over 52% of global volume share in 2023.

Oxygen Concentrators Market Trends

A key trend shaping the oxygen concentrators market is the miniaturization of portable units. In 2023, over 2.7 million units featured weights under 5 kg, allowing greater adoption among active elderly and ambulatory patients. Additionally, more than 1.1 million devices shipped in 2024 integrated smart connectivity with Bluetooth and mobile app support, enabling remote oxygen level monitoring and data sharing with physicians.

Battery technology is another evolving trend. Over 60% of portable concentrators released in 2023 used lithium-ion batteries with extended run times of 10 hours or more. This advancement meets the needs of patients in remote or rural areas lacking a continuous electricity supply. Units with dual power modes, supporting both battery and AC input, rose by 28% in global sales from 2022 to 2024.

Noise-reduction innovations are also being adopted. More than 740,000 units released in 2023 emitted less than 40 decibels of operational noise, enhancing usability in sleep environments. Similarly, auto-pulse delivery systems now allow adaptive oxygen output based on patient breathing rates, featured in over 900,000 devices sold globally.

Increased hospital-grade oxygen concentrators for acute care are also trending. Over 1.2 million high-flow oxygen concentrators were installed across global hospitals in 2023 to manage patients with severe hypoxemia. These units provided oxygen flow rates above 10 L/min, and their adoption increased by 31% from 2022 levels.

Finally, refurbished and rental concentrators gained popularity. In 2023, over 670,000 oxygen concentrators were rented, mainly across Latin America, Africa, and Southeast Asia. Refurbished units accounted for over 510,000 transactions globally, offering cost-effective solutions for budget-constrained patients and facilities.

Oxygen Concentrators Market Dynamics

DRIVER

Rising demand for respiratory care driven by chronic illnesses.

The oxygen concentrators market is primarily driven by the rising global prevalence of chronic respiratory conditions such as COPD, sleep apnea, and pulmonary fibrosis. In 2023, COPD affected over 390 million individuals worldwide, with nearly 19% requiring long-term oxygen therapy. The global aging population further contributes to market growth, as more than 770 million people aged 65 and above are prone to oxygen dependency. In the U.S. alone, over 720,000 patients were newly prescribed oxygen concentrators in 2023. Demand from post-operative and post-COVID recovery cases also surged, with over 1.3 million units procured by short-stay recovery centers globally.

RESTRAINT

High cost and maintenance complexity of advanced models.

While the adoption of oxygen concentrators is rising, high procurement and maintenance costs hinder market penetration, especially in low-income economies. Advanced portable units with integrated software and longer battery life often cost over 2.5x compared to basic models. In 2023, over 35% of healthcare providers in Sub-Saharan Africa cited cost as the primary barrier to adopting concentrators. Furthermore, maintenance complexity due to HEPA filter replacements, oxygen purity sensors, and compressor wear increases ownership costs. On average, servicing portable units costs over $120 annually, limiting their use in remote and underserved areas. Short device lifespans, often capped at 5,000 operational hours, also lead to quicker replacement cycles.

OPPORTUNITY

Integration of AI and IoT for personalized oxygen therapy.

The emergence of AI-integrated and IoT-enabled oxygen concentrators opens a new frontier in personalized respiratory care. In 2024, more than 820,000 smart oxygen concentrators were connected to digital healthcare ecosystems. These systems can auto-adjust flow based on patient blood oxygen saturation and breathing patterns. In countries like Japan and South Korea, 65% of new homecare concentrators in 2023 included built-in diagnostic features. AI can also predict compressor failure and oxygen purity deviations, reducing maintenance downtime by 22%. Voice-command and touchscreen-enabled oxygen concentrators are under development and expected to be deployed in over 50,000 units by 2025.

CHALLENGE

Shortage of skilled technicians and delayed servicing in remote areas.

A critical challenge in the oxygen concentrators market is the lack of trained service personnel and the time lag in replacement parts delivery. In 2023, over 310,000 concentrators across low-income nations became non-operational due to unresolved technical faults. Rural healthcare centers reported average servicing delays of 10–18 days. Additionally, only 16% of hospitals in Central Africa had in-house biomedical engineers capable of servicing advanced concentrator models. Training programs are limited in scale, with fewer than 9,000 technicians globally certified for multi-brand concentrator maintenance as of 2024. These constraints directly affect oxygen delivery continuity for patients dependent on consistent therapy.

Oxygen Concentrators Market Segmentation

The oxygen concentrators market is segmented by type and application. In 2023, portable oxygen concentrators held a dominant 52% market share by volume, while fixed oxygen concentrators accounted for 48%. By application, home care represented the largest segment, contributing over 61% of total device installations, followed by hospital care and outdoor care.

By Type

Portable Oxygen Concentrators: In 2023, global shipments of portable oxygen concentrators exceeded 3.7 million units. These devices are lightweight (under 5 kg), battery-powered, and cater to patients requiring mobile oxygen therapy. North America accounted for over 1.4 million units sold. More than 72% of portable units now offer pulse flow delivery with adjustable settings between 1–5 L/min. The inclusion of lithium-ion batteries enables up to 10–14 hours of usage on a single charge. Additionally, more than 1.1 million units shipped in 2024 included mobile app integration.
Fixed Oxygen Concentrators: Fixed oxygen concentrators are widely used in hospitals, nursing homes, and post-operative recovery centers. Over 3.3 million fixed units were deployed globally in 2023. These devices typically deliver continuous oxygen flow between 5–10 L/min and are equipped with dual filters, humidifiers, and digital oxygen sensors. China led this segment, with over 850,000 units installed in government hospitals. Fixed concentrators also dominate pediatric and ICU applications, with 96% of neonatal respiratory wards in Japan using hospital-grade stationary concentrators.

By Application

Home Care: The home care segment represented over 4.5 million units installed globally in 2023. North America led this segment with 1.9 million units, followed by Europe at 1.2 million units. Oxygen concentrators in this category support patients with long-term COPD and sleep apnea. Devices in this segment are optimized for user-friendly interfaces, remote monitoring, and energy efficiency.
Hospital Care: Over 1.9 million oxygen concentrators were deployed across hospitals worldwide in 2023. Units are utilized in emergency rooms, ICUs, and general respiratory wards. Flow rates above 10 L/min and reliability in 24/7 operations define hospital-grade concentrators. Approximately 68,000 hospitals globally now maintain centralized oxygen concentrator systems as part of their critical care protocols.
Outdoor Care: Outdoor applications accounted for more than 740,000 units in 2023. These include oxygen therapy devices used during transport, travel, and emergency evacuation. Compact and rugged concentrators, tested for operation in temperatures from −10°C to 45°C, were in demand across mountainous and remote areas.
Others: This segment includes use in ambulances, aviation, military bases, and sports medicine. Over 310,000 units were deployed in specialized applications in 2023. Air ambulances and military hospitals increasingly rely on oxygen concentrators due to their compactness and power efficiency during extended missions.

Oxygen Concentrators Market Regional Outlook

The oxygen concentrators market demonstrates strong performance across regions due to diverse healthcare needs and infrastructure investments.

North America

led the market in 2023, with the United States accounting for over 1.8 million oxygen concentrators sold. The rise in aging population, high COPD prevalence, and early adoption of home-based respiratory therapy support the market. Canada witnessed a 16% rise in portable concentrator sales, reaching 270,000 units. Government insurance coverage and Medicare reimbursements for oxygen therapy further accelerated adoption.

Europe

followed closely with over 1.6 million units sold in 2023. Germany, the UK, and France were leading markets, accounting for more than 950,000 units combined. The region saw increased procurement of high-flow concentrators in public hospitals and long-term care facilities. Regulatory support for digital health integration led to 520,000 units equipped with remote monitoring tools. Eastern Europe added over 110,000 units, largely supported by post-pandemic public health investments.

Asia-Pacific

witnessed the fastest expansion, with over 2.3 million units sold in 2023. China led with 1.2 million units, followed by India at 670,000 units. Japan and South Korea adopted more advanced models, including AI-enabled systems and voice-assisted concentrators. Government procurement programs in India and Indonesia distributed more than 420,000 oxygen concentrators in 2023 under national healthcare missions. The region also experienced increased exports from local manufacturers.

Middle East & Africa

MEA regions deployed over 630,000 oxygen concentrators in 2023. Saudi Arabia and the UAE led hospital-based demand, while Nigeria, Kenya, and South Africa focused on home care. The WHO’s oxygen aid programs distributed over 190,000 units across 22 countries in Africa. Challenges in maintenance and distribution logistics persist, but regional manufacturing hubs in Egypt and Morocco are emerging to reduce dependency on imports.

List of Top Oxygen Concentrator Companies

Inogen
NGK Spark Plug
Yuyue Medical
Invacare
Teijin Pharma
Philips
Linde
DeVilbiss Healthcare
ResMed
O2 Concepts
Air Water Group
Omron
Beijing Shenlu
Nidek Medical
Shenyang Canta
GF Health Products
Precision Medical
Daikin
Longfei Group
SysMed

Top Two Companies with the Highest Share

Imogen: leads the global market, with over 1.1 million portable oxygen concentrators sold in 2023. The company dominates the U.S. home care segment and exports to more than 45 countries.
Philips: holds the second-largest share, supplying over 940,000 units globally in 2023, with a strong presence in Europe and Asia-Pacific for both portable and hospital-grade concentrators.

Investment Analysis and Opportunities

The oxygen concentrators market is attracting significant investment due to rising demand, favorable healthcare policies, and technological advancement. In 2023, global investments in oxygen concentrator manufacturing and R&D exceeded 1.8 billion USD equivalent. Major countries like the U.S., China, India, and Germany led these investments with expanded facility upgrades, automation, and localization strategies. India alone announced over 220 million USD in investments to support oxygen concentrator manufacturing under its Production Linked Incentive (PLI) scheme.

Inogen expanded its production capabilities with a new 14,000 square meter facility in California, increasing output by 35% to meet North American demand. Meanwhile, Chinese firms including Yuyue Medical and Shenyang Canta invested a combined 430 million USD to increase their export capacity to Europe and Latin America. This resulted in a 21% increase in overseas shipments in 2023. Philips launched a global investment initiative focused on AI-integrated medical devices, with over 78 million USD allocated for smart oxygen concentrators in 2023 alone.

Private equity and venture capital are also fueling innovation. In 2023, five medical tech startups raised over 120 million USD in Series A and B funding rounds to develop next-generation portable concentrators and wearable oxygen delivery systems. Healthcare infrastructure funding in Africa saw over 95 million USD allocated to supply and maintain oxygen concentrators in 14 countries. NGOs and global aid agencies also channeled over 60 million USD for concentrator deployment in humanitarian zones.

Opportunities in digital integration and remote patient monitoring are surging. Over 820,000 oxygen concentrators sold in 2024 featured smart dashboards, enabling medical providers to manage oxygen therapy remotely. This presents an investment opportunity in cloud-based health platforms tailored for respiratory care. Additionally, niche market demand in aviation, military, and athletic rehabilitation is expanding. Specialized units with ruggedized design, temperature tolerance from −20°C to 50°C, and low-pressure oxygen generation present new revenue avenues.

By 2025, over 80% of oxygen concentrators are expected to be manufactured with modular designs that support component-level upgrades, opening investment pathways in aftermarket servicing, consumables, and software-based feature enhancements. The market remains fertile for innovation-driven investments with long-term yield prospects across both developed and emerging economies.

New Product Development

Innovation in the oxygen concentrators market is accelerating, with a sharp focus on personalization, portability, and digital integration. In 2023, over 70 new oxygen concentrator models were launched globally across different segments. These new models include advancements such as ultra-light design, extended battery life, real-time monitoring, and integrated connectivity.

Inogen introduced a new series of ultra-portable concentrators weighing just 2.1 kg and offering up to 10 hours of operation on a single charge. These models quickly gained traction in the U.S. and Europe, with over 180,000 units sold within 8 months. Philips launched an oxygen concentrator with an inbuilt voice assistant for visually impaired patients. Over 30,000 of these units were shipped to eldercare centers across the Netherlands and Germany.

NGK Spark Plug developed a quiet-mode fixed concentrator, emitting only 35 dB of operational noise. This innovation supports hospital sleep wards and palliative care centers. DeVilbiss Healthcare unveiled a high-capacity dual-patient concentrator capable of delivering oxygen to two patients simultaneously with flow rates up to 15 L/min. Over 12,000 of these were deployed in emergency facilities globally.

Battery and power innovations have also been central to new product development. In 2023, over 920,000 units shipped globally featured solar charging compatibility. This innovation was especially vital for off-grid regions in Sub-Saharan Africa and rural Southeast Asia. Manufacturers like Yuyue Medical also introduced modular designs that allowed battery swaps and filter cartridge replacements, improving maintenance convenience.

Furthermore, AI-powered oxygen flow regulation has entered production. Teijin Pharma developed an algorithm that predicts oxygen requirements based on sleep patterns and exertion levels, automatically adjusting output. Early trials across 1,500 patients in Japan showed a 17% improvement in therapy compliance. Omron developed a pediatric oxygen concentrator with adaptive nasal flow, offering gentle yet effective oxygen delivery for infants under 10 kg.

New product development is increasingly focused on software and diagnostics. Over 520,000 units shipped in 2024 included diagnostic modules for air quality assessment, altitude compensation, and auto-shutdown in unsafe environments. As regulatory bodies promote digital healthcare, companies are aligning product roadmaps to include mobile app integrations, GPS tracking, and remote troubleshooting capabilities.

Five Recent Developments

Inogen launched a sub-2.5 kg ultra-portable oxygen concentrator with 10+ hours of battery life in Q3 2023, selling over 180,000 units in North America by Q2 2024.
Philips introduced an AI-integrated smart oxygen concentrator with Bluetooth connectivity in January 2024, adopted by over 240 healthcare institutions in Europe.
Yuyue Medical completed a 200,000 unit shipment of solar-compatible concentrators to Southeast Asia and Africa in 2023 under a multilateral health aid agreement.
NGK Spark Plug unveiled a noise-suppressed stationary model in late 2023, achieving under 35 dB sound levels, with 42,000 units deployed in sleep centers globally.
DeVilbiss Healthcare began global distribution of dual-user high-capacity concentrators in mid-2024, targeting refugee health camps and mass casualty response units with a target supply of 50,000 units.

Report Coverage of Oxygen Concentrators Market

This comprehensive market report covers global and regional analysis of the oxygen concentrators market, providing quantitative insights into production volumes, application areas, pricing trends, technological shifts, and regulatory landscapes. Covering data from 2020 to 2024, the report includes projections through 2030, structured across four major regions and over 30 key countries.

The report encompasses segmentation by type—portable and fixed concentrators—and by application, including home care, hospital care, outdoor care, and others. The analysis details market penetration in both high-income and emerging economies, with shipment volumes and installation figures tracked annually. In 2023, the report documented over 7.1 million units sold globally, with over 3.7 million being portable variants.

Detailed manufacturer profiling includes over 20 leading companies, with insights into production capacity, R&D expenditure, regional facility locations, and product pipelines. The report benchmarks the top 10 companies by unit sales and market reach. It also covers government procurement contracts, aid-based deployments, and healthcare infrastructure partnerships driving market expansion.

Coverage extends to supply chain evaluation, including compressor sourcing, lithium-ion battery partnerships, and filter component manufacturing. The report tracks more than 60 global production sites and includes trade analysis of oxygen concentrator flows between Asia, North America, and Africa. Over 480,000 units were exported from China to over 60 countries in 2023, representing a critical component of international supply.

Technological analysis includes product design trends, innovations in AI and IoT integration, safety standards, and digital health compatibility. Compliance with medical regulatory frameworks such as FDA, CE, and ISO is documented for each regional market. Additionally, the report maps demand across population age groups, disease prevalence rates, and healthcare access disparities.

The oxygen concentrators market report offers actionable insights for manufacturers, healthcare institutions, investors, and policymakers, with 12 opportunity zones identified for high-yield investment and five emerging market clusters forecasted to grow rapidly through 2030. It serves as a strategic reference tool for navigating the evolving respiratory care landscape globally.